tiprankstipranks
Shield Therapeutics (GB:STX)
:STX
UK Market
Holding GB:STX?
Track your performance easily

Shield Therapeutics (STX) Technical Analysis

19 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Shield Therapeutics’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Shield Therapeutics is a Buy.
Shield Therapeutics’s (STX) 20-Day exponential moving average is 2.56, while Shield Therapeutics’s (STX) share price is 2.35p, making it a Sell.
Shield Therapeutics’s (STX) 50-Day exponential moving average is 2.81, while Shield Therapeutics’s (STX) share price is 2.35p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Jan 19, 2025, 07:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.99
2.13
2.27
2.41
2.56
2.70
2.84
Fibonacci
2.13
2.24
2.30
2.41
2.52
2.59
2.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Jan 19, 2025, 07:25 AM
Period
Simple
Exponential
MA5
2.34Buy
2.38Sell
MA10
2.48Sell
2.45Sell
MA20
2.60Sell
2.56Sell
MA50
2.71Sell
2.81Sell
MA100
3.48Sell
3.03Sell
MA200
2.80Sell
2.94Sell
Shield Therapeutics’s (STX) 10-Day exponential moving average is 2.45, while Shield Therapeutics’s (STX) share price is 2.35p, making it a Sell.
Shield Therapeutics’s (STX) 100-Day exponential moving average is 3.03, while Shield Therapeutics’s (STX) share price is 2.35p, making it a Sell.
Shield Therapeutics’s (STX) stock price is 2.35p and Shield Therapeutics’s (STX) 50-day simple moving average is 2.71, creating a Sell signal.
Shield Therapeutics’s (STX) stock price is 2.35p and Shield Therapeutics’s (STX) 100-day simple moving average is 3.48, creating a Sell signal.
Shield Therapeutics’s (STX) stock price is 2.35p and Shield Therapeutics’s (STX) 200-day simple moving average is 2.80, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

Jan 19, 2025, 07:25 AM
Name
Value
Implied Action
RSI (14)
33.94
Neutral
STOCH (9,6)
22.15
Neutral
STOCHRSI (14)
20.00
Buy
MACD (12,26)
-0.13
Buy
ADX (14)
18.20
Buy
Williams %R
-78.26
Buy
CCI (14)
-111.46
Buy
ATR (14)
0.15
-
Ultimate Oscillator
31.57
Neutral
ROC
-12.96
Sell
Shield Therapeutics’s (STX) Relative Strength Index (RSI) is 33.94, creating a Neutral signal.
Shield Therapeutics’s (STX) Trend Strength Indicator (ADX) is 18.20, creating a Buy signal.
Shield Therapeutics’s (STX) Commodity Channel Index (CCI) is -111.46, creating a Buy signal.
Shield Therapeutics’s (STX) Price Rate of Change (ROC) is -12.96, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 33.94, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is -0.13, which suggests STX is a Buy.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 2.34, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 2.60, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 2.71, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 2.80, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -78.26, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -111.46, which suggests STX is a Buy.
                    What is the share price of Shield Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis